Literature DB >> 7515662

Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region.

D L Van Dyke1, M J Worsham, M S Benninger, C J Krause, S R Baker, G T Wolf, T Drumheller, B C Tilley, T E Carey.   

Abstract

We characterized the breakpoints, gains, and losses of chromosome material in squamous cell carcinomas of the head and neck region from 29 patients. Cell lines were karyotyped in 1/3 of cases, direct preparations or early in vitro harvests in 1/3, and both in 1/3 of cases. GTG-banding was employed in all cases, as were C-banding and RBG- and AgNOR-staining in most. Some tumors were near-diploid and others near-tetraploid, but many had mixed populations, with diploid, tetraploid, and octoploid subclones representing essentially the same karyotypic pattern. The most frequent changes were deletions. Losses affecting 3p13-p24, 5q12-q23, 8p22-p23, 9p21-p24, and 18q22-q23 ranged in frequency from 40% to 60% of tumors. Loss of the short arm of the inactive X occurred in 70% of tumors from female patients, and loss or rearrangement of the Y occurred in 74% of tumors from male patients. Loss of 18q appeared to be associated with short survival, as did the presence of multiple deletions. There was gain (2-5 extra copies) of 3q21-qter, 5p, 7p, 8q, and 11q13-q23 in 28-38% of tumors. Three tumors had an hsr involving 11q13-q21. Gain of material at 11q13 is postulated to be associated with amplification of the PRADI/CCND gene at that locus. A translocation between proximal 1p and either an acrocentric short arm or proximal 8p or 9p was observed in squamous cell carcinomas of the head and neck region but not in female genital tract tumors. No other abnormalities appeared to be site specific, suggesting a pattern of genetic evolution in squamous cell carcinoma that is independent of anatomic site.

Entities:  

Mesh:

Year:  1994        PMID: 7515662     DOI: 10.1002/gcc.2870090308

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  37 in total

1.  Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.

Authors:  Md Golam Sabbir; Anup Roy; Syamsundar Mandal; Aniruddha Dam; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Epigenetic inactivation of galanin receptor 1 in head and neck cancer.

Authors:  Kiyoshi Misawa; Yo Ueda; Takeharu Kanazawa; Yuki Misawa; Ilwhan Jang; John Chadwick Brenner; Tetsuya Ogawa; Satoru Takebayashi; Reidar A Grenman; James G Herman; Hiroyuki Mineta; Thomas E Carey
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

3.  Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction.

Authors:  Z Chen; C W Smith; D Kiel; C Van Waes
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

4.  Molecular characterization of head and neck cancer: how close to personalized targeted therapy?

Authors:  Maria J Worsham; Haythem Ali; Jadranka Dragovic; Vanessa P Schweitzer
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

Review 5.  Delineating an epigenetic continuum in head and neck cancer.

Authors:  Maria J Worsham; Josena K Stephen; Kang Mei Chen; Shaleta Havard; Veena Shah; Glendon Gardner; Vanessa G Schweitzer
Journal:  Cancer Lett       Date:  2012-03-01       Impact factor: 8.679

6.  Allelic imbalance at chromosome 11 in head and neck squamous cell carcinoma in an Indian patient population.

Authors:  G Mondal; A Tripathi; N Bhattacharya; N Sikdar; A Roy; A Sengupta; B Roy; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 7.  [Surgical treatment options for squamous cell carcinoma of the oral cavity].

Authors:  Michael Rasse
Journal:  Wien Med Wochenschr       Date:  2008

8.  Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.

Authors:  Kiyoshi Misawa; Takeharu Kanazawa; Yuki Misawa; Atsushi Imai; Takayuki Uehara; Daiki Mochizuki; Shiori Endo; Goro Takahashi; Hiroyuki Mineta
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-19       Impact factor: 4.553

Review 9.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  DNA gains and losses of chromosome in laryngeal squamous cell carcinoma using comparative genomic hybridization.

Authors:  Ibrahim Keser; Ahter D Toraman; Gulay Ozbilim; Kenan Guney; Guven Luleci
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.